Rock Soffer - 13 Apr 2022 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
Director
Signature
/s/ Paul T. Lehr, attorney-in-fact
Issuer symbol
LGVN
Transactions as of
13 Apr 2022
Net transactions value
$0
Form type
4
Filing time
15 Apr 2022, 17:00:29 UTC
Previous filing
13 Oct 2021
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Other $0 +139,912 +270% $0.000000 191,669 13 Apr 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2 Shares received as part of distribution by DS Med, LLC, to its members for no consideration.
F3 Amount includes 139,912 shares of Class B Common Stock and 5,000 Restricted Stock Units subject to vesting.